NEUCA S.A. (WSE:NEU)

Market Cap	3.36B
Revenue (ttm)	13.04B
Net Income (ttm)	135.42M
Shares Out	4.48M
EPS (ttm)	29.76
PE Ratio	25.21
Forward PE	19.41
Dividend	16.00 (2.13%)
Ex-Dividend Date	Jul 15, 2025

Volume	1,238
Average Volume	1,438
Open	740.00
Previous Close	740.00
Day's Range	740.00 - 754.00
52-Week Range	636.00 - 900.00
Beta	0.57
RSI	66.38
Earnings Date	Nov 14, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.